To include your compound in the COVID-19 Resource Center, submit it here.

Summit proposes $25M private placement

Summit Therapeutics plc (LSE:SUMM; NASDAQ:SMMT) proposed on Dec. 17 to raise $25 million in a

Read the full 150 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE